NR1H4 ameliorates Parkinson’s disease via inhibiting astrocyte activation and neuroinflammation in a CEBPβ/NF-κB dependent manner
Article in International Immunopharmacology (September 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in International Immunopharmacology (September 2024)
Article in Biogerontology (July 2024)
Article in JHEP Reports (June 2024)